Literature DB >> 893665

Small airways in idiopathic pulmonary fibrosis. Comparison of morphologic and physiologic observations.

R G Crystal, J D Fulmer, W C Roberts, E R von Gal.   

Abstract

18 patients with idiopathic pulmonary fibrosis were studied to determine if they had morphologic evidence of small airways disease and if physiologic testing could predict morphologic findings. In the presence of normal airway function by standard physiologic studies (forced expiratory volume in 1 s/forced vital capacity and airway resistance by plethysmography), dynamic compliance, maximum expiratory flow-volume curves, and maximum flowstatic recoil curves were measured to detect physiologic alterations consistent with small airways abnormalities. These physiologic data were then compared with estimates of small airways diameter made in lung biopsy specimens.94% (17 of 18) of the patients had peribronchiolar fibrosis or peribronchiolar inflammation or bronchiolitis. 67% (12 of 18) had an overall estimate of small airways diameter of "narrowed," whereas 33% (6 of 18) had airways that overall were "not narrowed." 59% (10 of 17) had frequency-dependent dynamic compliance, 50% (9 of 18) had abnormal maximum expiratory flow-volume curves, and 39% (7 of 18) had abnormal maximum flow-static recoil curves. Comparisons between morphologic and physiologic data revealed a significant correlation between the results of dynamic compliance and the overall estimate of small airways diameter (P = 0.001), and the results of maximum flow-volume curves and the overall estimate of small airways diameter (P = 0.009); there was no significant correlation between the results of maximum flow-static recoil curves and the overall estimate of small airways diameter (P = 0.1). THE RESULTS OF THIS STUDY SUGGEST THAT: (a) idiopathic pulmonary fibrosis is a disease of small airways as well as alveoli; (b) dynamic compliance and the maximum expiratory flow-volume curve can predict the overall status of small airways diameter in idiopathic pulmonary fibrosis; and (c) whereas the maximum flowstatic recoil curve predicts the overall estimate of small airways diameter in most patients with this disease, it is the least sensitive of these three monitors of small airways.

Entities:  

Mesh:

Year:  1977        PMID: 893665      PMCID: PMC372404          DOI: 10.1172/JCI108811

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  54 in total

1.  IMPROVED TECHNIQUE FOR ESTIMATING PLEURAL PRESSURE FROM ESOPHAGEAL BALLOONS.

Authors:  J MILIC-EMILI; J MEAD; J M TURNER; E M GLAUSER
Journal:  J Appl Physiol       Date:  1964-03       Impact factor: 3.531

2.  Pathophysiology of interstitial pulmonary fibrosis. Report of 19 cases and follow-up with corticosteroids.

Authors:  F A HERBERT; B B NAHMIAS; E A GAENSLER; H E MACMAHON
Journal:  Arch Intern Med       Date:  1962-11

3.  The cause of arterial hypoxemia at rest in patients with "alveolarcapillary block syndrome".

Authors:  T N FINLEY; E W SWENSON; J H COMROE
Journal:  J Clin Invest       Date:  1962-03       Impact factor: 14.808

4.  Respiratory function tests; normal values at median altitudes and the prediction of normal results.

Authors:  H I GOLDMAN; M R BECKLAKE
Journal:  Am Rev Tuberc       Date:  1959-04

5.  Morphological aspects of interstitial pulmonary fibrosis.

Authors:  A E ANDERSON; A G FORAKER
Journal:  Arch Pathol       Date:  1960-07

6.  Chronic diffuse interstitial fibrosis of the lungs.

Authors:  J G SCADDING
Journal:  Br Med J       Date:  1960-02-13

7.  DIFFUSE INTERSTITIAL PULMONARY FIBROSIS.A CLINICAL, RADIOLOGICAL, AND PATHOLOGICAL STUDY BASED ON 45 PATIENTS.

Authors:  J L LIVINGSTONE; J G LEWIS; L REID; K E JEFFERSON
Journal:  Q J Med       Date:  1964-01

8.  The pathology of honeycomb lung.

Authors:  A G HEPPLESTON
Journal:  Thorax       Date:  1956-06       Impact factor: 9.139

9.  Mechanical factors in distribution of pulmonary ventilation.

Authors:  A B OTIS; C B MCKERROW; R A BARTLETT; J MEAD; M B MCILROY; N J SELVER-STONE; E P RADFORD
Journal:  J Appl Physiol       Date:  1956-01       Impact factor: 3.531

10.  THE VOLUME OF THE LUNG DETERMINED BY HELIUM DILUTION. DESCRIPTION OF THE METHOD AND COMPARISON WITH OTHER PROCEDURES.

Authors:  G R Meneely; N L Kaltreider
Journal:  J Clin Invest       Date:  1949-01       Impact factor: 14.808

View more
  39 in total

1.  Oxidants spontaneously released by alveolar macrophages of cigarette smokers can inactivate the active site of alpha 1-antitrypsin, rendering it ineffective as an inhibitor of neutrophil elastase.

Authors:  R C Hubbard; F Ogushi; G A Fells; A M Cantin; S Jallat; M Courtney; R G Crystal
Journal:  J Clin Invest       Date:  1987-11       Impact factor: 14.808

2.  Alpha 1-antitrypsin deficiency caused by the alpha 1-antitrypsin Nullmattawa gene. An insertion mutation rendering the alpha 1-antitrypsin gene incapable of producing alpha 1-antitrypsin.

Authors:  D Curiel; M Brantly; E Curiel; L Stier; R G Crystal
Journal:  J Clin Invest       Date:  1989-04       Impact factor: 14.808

3.  Evaluation of fibronectin gene expression by in situ hybridization. Differential expression of the fibronectin gene among populations of human alveolar macrophages.

Authors:  K Adachi; K Yamauchi; J F Bernaudin; P Fouret; V J Ferrans; R G Crystal
Journal:  Am J Pathol       Date:  1988-11       Impact factor: 4.307

4.  Vertical gradients of lung density in supine subjects with fibrosing alveolitis or pulmonary emphysema.

Authors:  A B Millar; D M Denison
Journal:  Thorax       Date:  1990-08       Impact factor: 9.139

5.  Small airways pathology in idiopathic pulmonary fibrosis: a retrospective cohort study.

Authors:  Stijn E Verleden; Naoya Tanabe; John E McDonough; Dragoş M Vasilescu; Feng Xu; Wim A Wuyts; Davide Piloni; Laurens De Sadeleer; Stijn Willems; Cindy Mai; Jeroen Hostens; Joel D Cooper; Erik K Verbeken; Johny Verschakelen; Craig J Galban; Dirk E Van Raemdonck; Thomas V Colby; Marc Decramer; Geert M Verleden; Naftali Kaminski; Tillie-Louise Hackett; Bart M Vanaudenaerde; James C Hogg
Journal:  Lancet Respir Med       Date:  2020-02-13       Impact factor: 30.700

6.  Upregulation of platelet-derived growth factor-A and -B gene expression in alveolar macrophages of individuals with idiopathic pulmonary fibrosis.

Authors:  I Nagaoka; B C Trapnell; R G Crystal
Journal:  J Clin Invest       Date:  1990-06       Impact factor: 14.808

7.  Modulation of airway inflammation in cystic fibrosis. In vivo suppression of interleukin-8 levels on the respiratory epithelial surface by aerosolization of recombinant secretory leukoprotease inhibitor.

Authors:  N G McElvaney; H Nakamura; P Birrer; C A Hébert; W L Wong; M Alphonso; J B Baker; M A Catalano; R G Crystal
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

8.  Association of bronchiolitis with connective tissue disorders.

Authors:  M Hakala; P Pääkkö; S Sutinen; E Huhti; O Koivisto; M Tarkka
Journal:  Ann Rheum Dis       Date:  1986-08       Impact factor: 19.103

9.  Extensive posttranscriptional deletion of the coding sequences for part of nucleotide-binding fold 1 in respiratory epithelial mRNA transcripts of the cystic fibrosis transmembrane conductance regulator gene is not associated with the clinical manifestations of cystic fibrosis.

Authors:  C S Chu; B C Trapnell; S M Curristin; G R Cutting; R G Crystal
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

10.  Fibronectin in human bronchopulmonary lavage fluid. Elevation in patients with interstitial lung disease.

Authors:  S I Rennard; R G Crystal
Journal:  J Clin Invest       Date:  1982-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.